Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aamdal

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Cancer Research|August 1, 1988
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cellsO Fodstad, I Kjønniksen, S Aamdal, et al.
Cancer Research|February 1, 1984
Phase I study of the plant protein ricinO Fodstad, G Kvalheim, A Godal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9. EORTC Early Clinical Trials GroupH L McLeod, M A Graham, S Aamdal, et al.
British Journal of Cancer|November 12, 2015
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporinY Andersson, O Engebraaten, S Juell, et al.
Cancer|June 1, 1984
Estrogen receptors and long-term prognosis in breast cancerS Aamdal, O Børmer, O Jørgensen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma GroupJ Verweij, G Catimel, A Sulkes, et al.
Cancer Research|November 1, 1992
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progressionV A Flørenes, S Aamdal, O Myklebost, et al.
International Journal of Cancer|January 3, 1996
Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanomaM Karlsson, U Jungnelius, S Aamdal, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2011
Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2bY Brandberg, S Aamdal, L Bastholt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanomaB Gerard, S Aamdal, S M Lee, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Cancer Research|August 1, 1988
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cellsO Fodstad, I Kjønniksen, S Aamdal, et al.
Cancer Research|February 1, 1984
Phase I study of the plant protein ricinO Fodstad, G Kvalheim, A Godal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9. EORTC Early Clinical Trials GroupH L McLeod, M A Graham, S Aamdal, et al.
British Journal of Cancer|November 12, 2015
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporinY Andersson, O Engebraaten, S Juell, et al.
Cancer|June 1, 1984
Estrogen receptors and long-term prognosis in breast cancerS Aamdal, O Børmer, O Jørgensen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma GroupJ Verweij, G Catimel, A Sulkes, et al.
Cancer Research|November 1, 1992
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progressionV A Flørenes, S Aamdal, O Myklebost, et al.
International Journal of Cancer|January 3, 1996
Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanomaM Karlsson, U Jungnelius, S Aamdal, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2011
Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2bY Brandberg, S Aamdal, L Bastholt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanomaB Gerard, S Aamdal, S M Lee, et al.
Pageof 7